We bring you the latest news from the healthcare about the health care in the United Kingdom.

vrijdag 5 oktober 2018

British Journal of Cancer - Table of Contents alert Volume  119 Issue 5

British Journal of Cancer

TABLE OF CONTENTS

Volume 119, Issue 5

In this issue
Editorial
Article
Correspondence
Also new
AOP

Editorial

The growing importance of radiation worker studies

Richard Wakeford

British Journal of Cancer 2018 119 :527 - 529; August 15, 2018; 10.1038/s41416-018-0134-6

Abstract | Full Text

Article

Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer

Yoichi Aoki, Kazunori Ochiai, Soyi Lim, Daisuke Aoki, Shoji Kamiura et al.

British Journal of Cancer 2018 119 :530 - 537; August 03, 2018; 10.1038/s41416-018-0206-7

Abstract | Full Text

Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study

Hongnan Mo, Jing Huang, Jiachen Xu, Xuelian Chen, Dawei Wu et al.

British Journal of Cancer 2018 119 :538 - 545; May 14, 2018; 10.1038/s41416-018-0100-3

Abstract | Full Text

Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission

Eliza A Hawkes, Zoe Loh, Ortis Estacio, Geoff Chong, Francis J Ha et al.

British Journal of Cancer 2018 119 :546 - 550; July 23, 2018; 10.1038/s41416-018-0183-x

Abstract | Full Text

Persistent inequalities in unplanned hospitalisation among colon cancer patients across critical phases of their care pathway, England, 2011–13

Camille Maringe, Bernard Rachet, Georgios Lyratzopoulos & Francisco Javier Rubio

British Journal of Cancer 2018 119 :551 - 557; August 15, 2018; 10.1038/s41416-018-0170-2

Abstract | Full Text

Trastuzumab and paclitaxel in patients with EGFR mutated NSCLC that express HER2 after progression on EGFR TKI treatment

Adrianus J. de Langen, M. Jebbink, Sayed M. S. Hashemi, Justine L. Kuiper, J. de Bruin-Visser et al.

British Journal of Cancer 2018 119 :558 - 564; July 31, 2018; 10.1038/s41416-018-0194-7

Abstract | Full Text

A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma

Angiolo Gadducci, Federica Grosso, Giovanni Scambia, Francesco Raspagliesi, Nicoletta Colombo et al.

British Journal of Cancer 2018 119 :565 - 571; July 30, 2018; 10.1038/s41416-018-0190-y

Abstract | Full Text

Significance of re-biopsy for recurrent breast cancer in the immune tumour microenvironment

Koji Takada, Shinichiro Kashiwagi, Wataru Goto, Yuka Asano, Katsuyuki Takahashi et al.

British Journal of Cancer 2018 119 :572 - 579; July 23, 2018; 10.1038/s41416-018-0197-4

Abstract | Full Text

Identification of beta-arrestin-1 as a diagnostic biomarker in lung cancer

Victoria El-Khoury, Mélanie Béland, Anna Schritz, Sang-Yoon Kim, Petr V. Nazarov et al.

British Journal of Cancer 2018 119 :580 - 590; August 06, 2018; 10.1038/s41416-018-0200-0

Abstract | Full Text

MiR-532-5p suppresses renal cancer cell proliferation by disrupting the ETS1-mediated positive feedback loop with the KRAS-NAP1L1/P-ERK axis

Wei Zhai, Junjie Ma, Rujian Zhu, Chen Xu, Jin Zhang et al.

British Journal of Cancer 2018 119 :591 - 604; August 07, 2018; 10.1038/s41416-018-0196-5

Abstract | Full Text

Accreditation, setting and experience as indicators to assure quality in oncology biomarker testing laboratories

Véronique Tack, Ed Schuuring, Cleo Keppens, Nils 't Hart, Patrick Pauwels et al.

British Journal of Cancer 2018 119 :605 - 614; August 24, 2018; 10.1038/s41416-018-0204-9

Abstract | Full Text

Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group

David S. Shulman, Kelly Klega, Alma Imamovic-Tuco, Andrea Clapp, Anwesha Nag et al.

British Journal of Cancer 2018 119 :615 - 621; August 21, 2018; 10.1038/s41416-018-0212-9

Abstract | Full Text

Carbonic anhydrase IX is a pH-stat that sets an acidic tumour extracellular pH in vivo

Shen-Han Lee, Dominick McIntyre, Davina Honess, Alzbeta Hulikova, Jesús Pacheco-Torres et al.

British Journal of Cancer 2018 119 :622 - 630; September 12, 2018; 10.1038/s41416-018-0216-5

Abstract | Full Text

Cancer mortality and incidence following external occupational radiation exposure: an update of the 3rd analysis of the UK national registry for radiation workers

Richard G. E. Haylock, Michael Gillies, Nezahat Hunter, Wei Zhang & Mary Phillipson

British Journal of Cancer 2018 119 :631 - 637; August 15, 2018; 10.1038/s41416-018-0184-9

Abstract | Full Text

Cigarette smoking and thyroid cancer risk: a cohort study

Ara Cho, Yoosoo Chang, Jiin Ahn, Hocheol Shin & Seungho Ryu

British Journal of Cancer 2018 119 :638 - 645; August 15, 2018; 10.1038/s41416-018-0224-5

Abstract | Full Text

Excess body weight, weight gain and obesity-related cancer risk in women in Norway: the Norwegian Women and Cancer study

Marisa da Silva, Elisabete Weiderpass, Idlir Licaj, Lauren Lissner & Charlotta Rylander

British Journal of Cancer 2018 119 :646 - 656; September 11, 2018; 10.1038/s41416-018-0240-5

Abstract | Full Text

Correspondence

Comment on 'Impact of NICE guidance on tamoxifen prescribing in England 2011-2017: an interrupted time series analysis'

Keith Hopcroft

British Journal of Cancer 2018 119 :657 - 657; August 21, 2018; 10.1038/s41416-018-0205-8

Abstract | Full Text

Reply to Comment on 'Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis"

Helen Curtis & Ben Goldacre

British Journal of Cancer 2018 119 :658 - 658; August 21, 2018; 10.1038/s41416-018-0226-3

Abstract | Full Text

Advertisement
Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours.

Click here to sign up.
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

This email has been sent to dezorgsector.uk@gmail.com.

If you no longer wish to receive the email alerts from British Journal of Cancer click here to unsubscribe .
If you wish to discontinue all email services from Nature Research please click here to unsubscribe .

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature Research | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.

Springer Nature